The Scale of the Decline
Oracle finds itself in one of the most challenging positions in its recent history. Down 53% from its September highs near $345, the stock has earned the dubious distinction of being the worst-performing name in the S&P 500 over that span. Even on a year-to-date basis, the damage exceeds 20%, placing it among the 25 weakest stocks in the index. While many software names have enjoyed 10 to 15 days of positive momentum in recent weeks, Oracle simply cannot seem to get out of its own way.
The Debt Dilemma at the Heart of the Decline
The root cause of Oracle's troubles is not a mystery — it is debt. Oracle was one of the earliest major companies to aggressively leverage its balance sheet to finance AI expansion, and that strategy has now pushed its debt liabilities to approximately $100 billion. After outlaying $18 billion last year, the company anticipates spending another $45 to $50 billion this year on AI infrastructure buildout. This staggering capital commitment has created what can only be described as a cash crunch.
The bond market is sounding alarms. Credit default swaps on Oracle's 5-year debt have surged past 160 basis points — the worst levels the company has seen since the global financial crisis of 2008. Investors holding Oracle debt are demanding significant premiums for the risk, a clear sign that confidence in the company's financial trajectory has eroded.
The Abilene Data Center Setback
Adding to the pressure, Oracle and OpenAI recently scrapped plans to expand their flagship AI data center in Abilene, Texas. The decision was driven by a combination of financing difficulties and OpenAI's evolving technology needs. OpenAI wants to deploy the latest NVIDIA chips rather than operate facilities with a mix of older and newer hardware. This cancellation, alongside reported troubles with data center projects in Michigan and New Mexico, raises serious questions about whether Oracle can successfully execute on its massive infrastructure ambitions.
The Central Question for Investors
The critical issue facing Wall Street is straightforward: can Oracle convert these enormous investments into high-margin business? Free cash flows are beginning to drain, and profitability may be pushed further down the road. This uncertainty explains why investors have not rushed back into the stock despite the massive retracement. Oracle's leadership has historically found ways to navigate difficult periods, whether through mergers and acquisitions or strategic investments, but the current moment demands more than a track record — it demands clarity.
With Oracle reporting quarterly results — analysts expecting $1.70 per share in adjusted earnings on roughly $16.9 billion in revenue, up from $14.1 billion a year ago — the earnings call represents a critical opportunity to address investor anxiety. However, it is worth noting that Oracle has missed revenue estimates in eight of the past ten quarters, a pattern that does little to inspire confidence.
Reading the Technical and Options Tea Leaves
From a technical perspective, the picture is mixed but not without glimmers of hope. The stock sits just above its 200-week moving average — a significant long-term support level — though it remains below its 21-day exponential moving average. The RSI reading of 43 shows modest improvement, and perhaps more interestingly, the ADX indicator (Average Directional Index) has pulled back to around 20, below the 25 threshold that signals strong trend momentum. This suggests the ferocity of the downtrend may be losing steam, even if a reversal is far from guaranteed.
The options market tells its own story. Implied volatility sits at the 82nd percentile rank — extremely elevated, as one would expect heading into a binary earnings event for a stock that has been this volatile. The options market is pricing in roughly a $13 move, which translates to approximately a 9 to 9.5% single-day swing on a $150 stock. Notably, call-side activity has recently outpaced put activity by a ratio of two to one, and the options skew — which had been heavily favoring puts — has begun to even out. Some speculators are clearly betting that the bar has been set low enough for a positive surprise.
Two Strategic Approaches for an Uncertain Outcome
The Passively Bullish Case: Selling Premium
For those who believe the worst may be priced in, a short put vertical spread offers an intriguing risk-reward profile. Consider selling the $139/$134 put spread on the nearest weekly expiration — a $5-wide spread collecting roughly $1.25 in credit. This trade risks $375 to make $125, with a break-even at approximately $137.75. The probability of the $139 short strike expiring out of the money sits around 73%, meaning the odds favor profitability.
What makes this approach particularly compelling is the elevated implied volatility environment. The front-month options are so richly priced that extending the trade by an additional week only captures an extra nickel in credit — hardly worth seven more days of risk. This concentration of premium in the nearest expiration is a direct consequence of the earnings event and creates favorable conditions for premium sellers.
Even if the stock does not rally — even if it drifts modestly lower to around $140 — this position can still be profitable. It is a strategy built not on conviction that Oracle will soar, but on the more modest thesis that the stock will not collapse further from already depressed levels.
The Directionally Bearish Case: The Put Diagonal
For those less convinced that Oracle can stabilize, a bearish put diagonal offers a way to express downside conviction while managing cost. This involves buying an at-the-money $150 put in a slightly longer-dated expiration while simultaneously selling a $135 put in the nearer-term weekly options. The debit paid — roughly $650 to $670 — represents the maximum risk.
The elegance of this structure lies in the volatility dispersion. The longer-dated put carries implied volatility around 93%, while the near-term short put reflects approximately 137% implied volatility. By selling the more expensive near-term option against the cheaper longer-dated one, the trader finances a meaningful portion of the position. The stock needs to decline below approximately $145 to $146 for profitability, with the apex of the position around $135. If Oracle retests its early February lows near $137 to $138, this trade performs exceptionally well.
The Sweet Spot
Interestingly, both strategies find their ideal scenario in roughly the same zone. A decline to the $139 to $140 range would place both the bullish and bearish trades in profitable territory — the put spread by remaining above its short strike, and the diagonal by capturing sufficient downside movement. This convergence suggests that the market itself views this range as a high-probability landing zone, a kind of gravitational center for Oracle's post-earnings price action.
What ultimately matters is what Oracle communicates about its path forward. The investments are made. The debt is on the books. Now the market needs to hear that these bets are beginning to pay off — that the AI infrastructure buildout is translating into real, high-margin revenue. Without that clarity, even a stock down 55% may struggle to find a floor.